The Infectious Diseases Society of America (IDSA) recently updated the guidelines and recommendations for the treatment of COVID-19 based on efficacy and safety reports from various clinical trials. Use of inhaled corticosteroids in patients with COVID-19: Conclusion and recommendations Inhaled corticosteroids can be used for patients with mild to moderate COVID-19. Inhaled corticosteroids cannot be used for patients with immunosuppression or severe COVID-19, as they may be at risk of Cushing’s syndrome or adrenal suppression. More research is recommended to study the interaction of corticosteroids with the nirmatrelvir/ritonavir course of treatment.
Stay tuned for IDSA recommendations on the use of convalescent plasma for COVID-19 patients! To get an overview of treatment guidelines for different types of COVID-19 patients, check out this infographic! To know IDSA recommendations on…
